Purpose There is substantial need for optimizing radiation protection in nuclear medicine imaging studies. However, the diagnostic reference levels (DRLs) have not yet been established for nuclear medicine imaging studies in Korea.
Introduction
There is substantial need to establish diagnostic reference levels (DRLs) in nuclear medicine imaging studies to reduce unjustified medical radiation exposure and social concerns, as well as to optimize radiation protection. DRL was first introduced in the International Commission on Radiation Protection (ICRP) Publication 73 [1] . It is a form of investigation level, which applies to an easily measured quantity, usually the administered activity (MBq) in nuclear medicine imaging studies. However, as DRL is recommended to avoid excessive radiation exposure to patients while maintaining sufficient image quality, it should not be applied as a dose constraint or dose limit [2] . In 1999, the European Commission published the Radiation Protection 109 [3] and stated that DRLs should be set by member states under consideration of individual national or regional circumstances such as the availability of equipment and training under the Radiation Protection 180 [4] . ICRP supported the establishment of DRL through publications following ICRP 73, including a practical supporting guidance [5] and the ICRP 105 [6] in 2001 and 2007, respectively. The most recent publication, ICRP 135 [7] , specifies existing guidelines and various aspects of DRL establishment such as considerations for conducting national survey, clinical applications of DRLs, and appropriate intervals for DRL's updates. Following these instructions, DRLs have been established in many countries [8] [9] [10] [11] [12] [13] [14] .
In Korea, the first national radiation dose survey was conducted in patients undergoing chest radiography and mammography in 2008, and a second national survey was conducted in 2016 to update the DRL. However, since DRLs were not established for nuclear medicine imaging, the International Atomic Energy Agency (IAEA) suggested that the Nuclear Safety and Security Commission (NSSC) of Korea establish DRLs in nuclear medicine imaging studies via the Integrated Regulatory Review Service (IRRS). Therefore, the Medical Radiation Safety Research Center (MRSRC) and Korean Society of Nuclear Medicine (KSNM) collected and analyzed the data of administered activity for nuclear medicine imaging in Korea. The KSNM DRL Task Force was founded and established confirmative DRL values through 32 nuclear medicine imaging studies in Korean adults. In this study, the establishment process of the first DRLs for nuclear medicine imaging studies in Korea is presented.
Materials and Methods

Data Collection
The data of administered activity in nuclear medicine imaging studies were collected from the KSNM dose survey database of two consecutive years, 2013 and 2014. The administered activity of each nuclear medicine imaging study was reported by the departmental representative of each institute using the on-line nuclear medicine protocol information network (http:// www.ksnm.or.kr/stats) created by the KSNM. In total, 144/ 148 (97.3%) and 142/148 (95.9%) hospitals provided dose data in 2013 and 2014, respectively. The data for 2013 were entered between April 11, 2014, and January 30, 2015, while the data for 2014 were entered between August 10, 2015, and January 30, 2016. The four centers which did not respond to the 2013 survey were those with nuclear medicine blood sample studies only. Two centers had closed nuclear medicine services in 2014 which led to the decreased number of total nuclear medicine centers and those with responses.
The analysis subjects included 28 nuclear medicine imaging studies as major categories. However, final DRL was calculated through 32 nuclear medicine imaging studies due to diverse protocols for brain and myocardial perfusion imaging. . Regarding gated cardiac blood pool scan, DRL was calculated for both the planar and SPECT images. Although the majority of PET studies were performed using hybrid PET/computed tomography (CT) images, the survey was limited to the administered activity of radiopharmaceuticals independent of CT dose. Nuclear medicine imaging studies included in the survey are presented in Table 1 .
Final Establishment of DRL
After completion of the data collection, the KSNM DRL Task Force members (21 nuclear medicine physicians) were selected from the board of the KSNM Radiation Safety Committee on February 24, 2016. The preliminary DRL values were reviewed by the Task Force members at the first (March 31, 2016) and second (May 31, 2016) meetings. The draft of the DRL for nuclear medicine imaging studies in Korea was confirmed at the third meeting, which was convened on September 12, 2016. The Task Force suggested the third quartile value (Q3) as the DRL as for CT images [15] and many previous nuclear medicine imaging studies [10, [16] [17] [18] . The DRL draft underwent the approval process of the KSNM Board of Trustees on October 10, 2018, and was reported to the KSNM Council on October 28, 2018. It was announced to the members of the KSNM as a draft on October 29, 2018.
DRL values from the announced draft were reviewed by domestic institutes performing nuclear medicine imaging studies in the clinical field for 3 months (January 2017 to March 2017). Opinions and suggestions were collected via questionnaires sent to the institutes and reflected in the revised version of the DRL draft. Additional survey for diverse study protocols of the brain and myocardial perfusion SPECT was conducted between August and September 2017 to confirm the final version of the DRL.
Statistical Analyses
Minimum (min), maximum (max), mode, median, median, first quartile (Q1), Q3, range (max-min), and standard deviation (SD) were calculated as descriptive statistics. The trends of changes in the values were examined by comparing individual descriptive statistics between 2013 and 2014. In case of outliers, the exact value was confirmed via phone interview by the department representative. All statistical analyses were performed with SPSS ver. 21.0 (SPSS Inc., USA) and R version 3.1.2 (The R Foundation for Statistical Computing, Austria) for Windows.
Results
Data were collected from 32 nuclear medicine imaging studies according to the radiopharmaceuticals and protocols used. Dose distribution (min, max, Q1, Q2, Q3, mean ± SD) of the 32 nuclear medicine imaging studies in adults is shown in Table 1 . DRLs for diverse protocols of the brain and myocardial perfusion SPECT are shown in Tables 2 and  3, These results are probably due to a relatively homogeneous distribution of the administered activity among domestic institutes, which is considered as a good condition for achieving consensus. There was no Q3 value, which was considered impractical or adjusted through expert opinion (Table 1) .
Comparison between the confirmed DRLs in Korea and values abroad (Japan, Australia, UK, Brazil, USA Tc-HMPAO-W B C ( l e u k o c y t e s c a n ) a n d 9 9 m Tc -m e b r o f e n i n (hepatobiliary scan) which showed the highest DRL values. Other abbreviations are as in Table 1 All radioactivity values are in MBq CZT, cadmium-zinc-telluride
Other abbreviations are as in Table 1 All radioactivity values are in MBq
Discussion
The first DRLs for nuclear medicine imaging studies in Korean adults were established through the process presented in our study. The values were derived through a 4-year research proposed in the IAEA IRRS review in 2014. DRLs can be used to optimize radiation protection by setting the appropriate level of administered activity in adult patients undergoing nuclear medicine imaging. Application of Q3, which is the same standard as in other studies to establish the DRLs of nuclear medicine imaging, was confirmed as appropriate for domestic nuclear medicine imaging studies. This value was consistent with the actual prescribed dose in majority domestic institutions reported in the KSNM dose survey and enabled consensus on the DRL in Korea.
In case the value of any DRL is exceeded, possible reasons should immediately be investigated and if corrective action is required, a plan should be implemented (and documented) without undue delay [7] . Nevertheless, DRL should not be regarded as an index of good (or bad) medical practice, but as supplemental data for professional decision-making. Sometimes, it is inevitable to maintain administered activity to achieve adequate image quality due to relatively old SPECT and/or PET cameras. It is not appropriate to adjust the administered activity to the lowest possible level but similar to that of DRL [10] . Moreover, DRL values are not considered as limits, and the highest priority for any diagnostic examination is to achieve sufficient image quality [1, 2, 7] . Therefore, DRLs should not be used as evidences for legal restriction or insurance coverage, which was suggested as a potential concern during the expert discussion. Some institutes (25%) are expected to show higher level of administered activity than that of DRL since it is defined as the Q3 of domestic administered activity. Therefore, as the medical environment changes, the DRL values should be continuously reviewed and updated at the appropriate interval of 5 years [18] . Ongoing technological advancement in the field of PET and SPECT cameras is expected to lead to decreased levels of administered activity under nuclear medicine imaging and consequently in the DRL. DRL for multi-detector CT has shown decreasing value at periodic review every 5th year in the UK [18] . Since the Korean DRL values may also decline in the future, periodical review and reestablishment are warranted.
Study Limitations
The present study has some limitations. First, the administered activity alone was analyzed without evaluation of the image quality. However, it may be difficult to assess the image quality objectively as it involves not only administered activity but also the use of different hardware and readers' preferences. Improvements in objective/ quantitative parameter, such as full-width half maximum, do not guarantee improved diagnostic test accuracy and can be a source of confusion in analyzing the collected data. Second, the administered activity in children was not analyzed. Since children are more sensitive to ionizing radiation, several tools are available for pediatric nuclear medicine imaging studies [19] [20] [21] . The European Association of Nuclear Medicine pediatric dosage card [19] is commonly used, which can lead to much lower administered activity than actual pediatric dosing in domestic institutes. DRLs should additionally be established for pediatric nuclear medicine imaging studies in the future. Lastly, DRLs for the CT component of hybrid imaging should be established as the proportion of PET/CT and SPECT/CT is high with trend of further increases [22, 23] . In Korea, DRLs for regional diagnostic CT scans were previously suggested [24, 25] .
However, the values are not applicable for the CT component of hybrid nuclear medicine imaging studies, and independent DRL values should be established in the future.
Conclusions
The first DRLs through 32 nuclear medicine imaging studies in Korean adults have been confirmed. The values should be periodically reviewed and updated. The DRLs enable the optimization of radiation protection in the field of nuclear medicine imaging in Korea.
